Jody Spain, APRN
Obstetrics & Gynecology · Poplar Bluff, MONPI 1427364744
Payments from drug & device makers
Across 93 payments — averaging $17.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$226
- Sumitomo Pharma America, Inc.$214
- Organon$172
- Exeltis, USA Inc.$119
- Amgen$115
- Organogenesis Inc.$81
- plus $705 from 19 others
What the payments were for
- Food & beverage$1,630100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $226 |
| Sumitomo Pharma America, Inc. | 13 | $214 |
| Organon | 13 | $172 |
| Exeltis, USA Inc. | 6 | $119 |
| Amgen | 6 | $115 |
| Organogenesis Inc. | 1 | $81 |
| Eisai Inc. | 5 | $81 |
| Merck | 4 | $65 |
| Novo Nordisk | 3 | $64 |
| Astellas Pharma US Inc | 3 | $55 |
| Evofem Biosciences, Inc. | 3 | $52 |
| Myovant Sciences Inc. | 3 | $48 |
| Johnson & Johnson | 2 | $45 |
| Dexcom, Inc. | 2 | $40 |
| Galderma Laboratories, L.p. | 1 | $37 |
| Radius Health, Inc. | 2 | $34 |
| Avanos Medical | 2 | $33 |
| Idorsia Pharmaceuticals US Inc | 2 | $29 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Axonics, Inc. | 1 | $20 |
| Bayer | 1 | $18 |
| Mayne Pharma Commercial LLC | 2 | $18 |
| Lilly USA, LLC | 1 | $17 |
| LSI Solutions Inc | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $12 |
How this compares
$1,630 in reported general payments places this provider in the 70th percentile of 750 obstetrics & gynecology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 15 | $3,435 |
| Estradiol | 73 | $2,997 |
| Clindamycin Phosphate | 33 | $2,286 |
| Clobetasol Propionate | 46 | $1,450 |
| Methenamine Hippurate | 11 | $788 |
| Fluconazole | 50 | $712 |
| Nystatin | 33 | $433 |
| Triamcinolone Acetonide | 33 | $163 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $159 |
| Gabapentin | 28 | $124 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Poplar Bluff
- Carrie CardaPoplar Bluff$22K
- Thomas ShultzSpringfield$1.1M
- Kent BransonCreve Coeur$576K
- Saji JacobSt. Louis$411K
- Becky LynnSaint Louis$231K
- Timothy HallIndependence$172K
- Craig McCoyMoberly$101K
- Andrew DavisSt. Louis$75K
- Richard GutknechtIndependence$65K
- Amanda CarrollFestus$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.